Skip to content

Clinical trials

Phase 2/3 Rare Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Phase: Phase 2/3 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon1
Icahn School of Medicine at Mount Sinai1
Institut National de la Santé Et de la Recherche Médicale, France1
Napo Pharmaceuticals, Inc.1
National Center for Research Resources (NCRR)1
Rapa Therapeutics LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases6
Amyotrophic Lateral Sclerosis1
Arthritis1
Arthritis, Juvenile1
Communicable Diseases1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Connective Tissue Diseases1
Dystonia1
Immune System Diseases1
Lupus Erythematosus, Systemic1

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.